Kidney Dialysis Market is expected to reach a revenue of USD 143.8 Bn by 2032, at 6.2% CAGR: Dimension Market Research [Yahoo! Finance]
DaVita Inc. (NYSE: DVA) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
DaVita Inc. (NYSE: DVA) had its price target raised by analysts at Barclays PLC from $133.00 to $150.00. They now have an "equal weight" rating on the stock.
DaVita HealthCare (DVA) is a Top-Ranked Value Stock: Should You Buy? [Yahoo! Finance]
Is DaVita (DVA) a Great Value Stock Right Now? [Yahoo! Finance]